-+ 0.00%
-+ 0.00%
-+ 0.00%

**TG Therapeutics to present BRIUMVI data at AAN 2026 annual meeting**TG Therapeutics Inc. will present two poster sessions on BRIUMVI (ublituximab-xiiy) data in relapsing forms of multiple sclerosis at the American Academy of Neurology 2026 annual meeting in Chicago

Reuters·03/06/2026 12:30:33

Please log in to view news